TOP

セッション一覧

  • Veeva Systems Inc. Founder & CEO Peter Gassner
  • Veeva Systems Inc. General Manager - CRM Products Arno Sosna
  • Veeva Club Chairman, AbbVie GK IT Director, Business Technology Solutions Yoichiro Ishikawa
  • Veeva Japan K.K. General Manager, Japan Takashi Okamura
  • Veeva Japan K.K. Japan Commercial, Vice President Yosuke Uchida

Keynote 2021 Veeva Vision/TBD

TBD
  • DX JAPAN Co., Ltd. Representative Director Daisuke Ueno
  • Astellas Pharma Inc. Senior Vice President, Information Systems Shinya Suda
  • Sumitomo Dainippon Pharma Co., Ltd Senior Director, MarTech Strategy Office / Specially Appointed Professor (Visitor), Tohoku University Kyoichi Yokota
  • Veeva Japan K.K. Vice President, Strategy and Customer Success, Commercial Japan Vice President Daisuke Harada

Session Critical Factors for Driving Digital Transformation in Pharma

We hear about DX in the media, inside our copanys, and everywhere else, and digital is being used to interact with physicians in commercial activitys. In this session, we will discuss what DX is, what the goals of DX are, and what mindset and actions are required for each person involved in DX? This session will provide insights from outside of the pharmaceutical, as well as implications for those working on DX from leaders inside and outside the pharmaceutical industry.
  • Amgen K.K. Head, Customer Engagement Innovation Group Kyoichi Nishimoto
  • Veeva Japan K.K. Manager, Customer Success Ryota Nishida

Session Challenging Digital Marketing to Connect with Customers

Pharmaceutical companies are lagging behind the general industry in digital marketing, but we think that existing channels are abundant.
Here, we would like to share the utilization status of the customer's action data and the results of timely communication.
  • Gilead Sciences K.K. Senior Director, Commercial Operations Junko Kimura
  • Veeva Club Chairman, AbbVie GK IT Director, Business Technology Solutions Yoichiro Ishikawa

Connect DX, People, and Organizations: What We Need to Do Now for DX

Why are "people" and "organizations" the key to change? We will look back at the environment surrounding us and the recent changes in people and organizations.
What has advanced and what has stagnated in DX in commercial activities? What needs to be accelerated in the future?
We plan to have an interactive session with the participants.
  • AbbVie GK Group Manager, Infield Team Excellence, Customer Excellence Takashi Iwai
  • AstraZeneca K.K Manager, Customer Engagement Transformation Department, Commercial Excellence Mizuho Kitagaki
  • Incyte Biosciences Japan G.K. Head of Corporate Excellence, Corporate Excellence Yoko Nishida

Connect V-Katsu! A meeting to consider multi-channel activities and their management - the last meeting

We have been discussing and debating about multi-channel activities and their management with the members of V-Katsu! This presentation will summarize the multichannel sales activities and their management that we have been discussing and debating with our members at V-Katsu!
  • Nara Medical University, Graduate School of Medicine Professor, Institute for Clinical and Translational Research Masato Kasahara
  • Pharmedico K.K. President & Managing Director / MD, PhD Kenji Hazama
  • Osaka University, Graduate School of Medicine / Faculty of M MD, PhD Kazuo Omori
  • Veeva Japan K.K. Vice President, Strategy and Customer Success, Commercial Japan Daisuke Harada

Session Communication, suggestion from doctors

As pandemic continues, new attempts are being made to communicate with physicians, mainly through digital, but at the same time, new challenges are found. Through the discussion with physicians , we will provide implications of "the essence of communication" to Pharma marketers.
  • Astellas Pharma Inc. Manager, Corporate & Commercial Partner Group Shuhei Okazaki
  • Astellas Pharma Inc. Information Systems Hideki Yamauchi
  • Veeva Japan K.K. Account Executive, Commercial Sales Ryu Yaegashi

Session Evolution of owned media integration for PromoMats

We will look back on the basic usage from the introduction of PromoMats in Astellas, and then introduce the effective and efficient utilization, owned media integration, and evolution to globalization.
  • Merck Biopharma Co., Ltd. Head, Data Management & Analytics Masahiro Nitta
  • Janssen Pharmaceutical K.K. Manager, Commercial Excellence Dep Customer Engagement Div Digital Engagement & CRM Group Tooru Iwagishi

Connect "DX, People, and Organizations" As a provider of information, changes in the construction, planning, and use of digital technology and how to move forward

It has been a year in which the people in charge of front-line activities, as well as those who plan and support those activities, have had to respond to changes most quickly in the organization.
In order to get them to respond to these changes in the field, I am sure they have accumulated a variety of experiences, some of which did not go well and some of which brought better results than expected. In this session, I would like to share various experiences with the participants and have an active discussion where we can freely exchange opinions on what we can do in the next year.
  • AstraZeneca K.K Manager, Customer Engagement Transformation Department, Commercial Excellence Manager Mizuho Kitagaki
  • Incyte Biosciences Japan G.K. Head of Corporate Excellence, Corporate Excellence Yoko Nishida
  • AbbVie GK Group Manager, Infield Team Excellence, Customer Excellence Takashi Iwai

Connect Toward the realization of omni-channel in the pharmaceutical industry

We will share issues such as platforms for data utilization and involvement of MRs that are necessary for omni-channel promotion, and discuss actions necessary to realize a field-driven omni-channel.
  • Aktana International LLC

Sponsor English not available

  • M3 Digital Communications, Inc.

Sponsor English not available

  • Encise Inc.

Sponsor English not available

  • Amazon Web Services Japan K.K.

Sponsor TBD

TBD
  • BIGM2Y, Inc.

Sponsor English not available

  • MEDICT INC.

Sponsor English not available

  • Salesforce.com, inc.

Sponsor TBD

TBD
  • MSD K.K. Product Owner, Data Solution Adoption and Stewardship Squad Kiyoshi Furukawa

Session What kind of data utilization will be required by pharmaceutical companies in the future?

From 2020 onwards, due to the spread of new coronavirus infections, MSD's promotional activities are undergoing major changes in both acute and chronic areas. We are aiming to develop our business by rapidly moving our promotional activities to remote locations (remote interviews/lectures) and building a new customer engagement model that utilizes rapid data maintenance and data. This presentation will introduce the efforts and challenges in these activities.
  • Bristol-Myers Squibb K.K. Digital Marketing Lead, Engagement & Channel Planning (APAC) Shigeto Miyamoto

Session TBD

TBD
  • MEDICEO CORPORATION Director, General Manager of Sales Division, Sales Division Hiroyuki Shibano

Session Pharmaceutical wholesale business With (After) Corona

Due to changes in the business environment surrounding pharmaceutical wholesalers, pharmaceutical wholesalers are under pressure to change their business style.
There are many changes in the environment that are imposed on the distribution and sales of pharmaceutical wholesalers such as annual drug price revisions, drug category changes, sales information provision activity guidelines, and proper drug distribution (GDP).
In addition, the new issue of drug distribution under the situation of COVID-19 has brought upon an opportunity to fundamentally review not only logistics but also the way information is provided.
There are high expectations for Veeva to build an information supply chain to function as an information hub.
  • AstraZeneca K.K Director, Customer Engagement Transformation Department, Commercial Excellence Atsushi Yamashita
  • Amgen K.K. Head, Customer Engagement Innovation Group Kyoichi Nishimoto
  • Infront inc. Leader, Interactive Communication Design division Hiroyuki Kamada

Connect DX, People, and Organizations: What we can do now to strengthen marketing capabilities in the pharmaceutical industry

The way we provide information to our customers is changing drastically, and many of us are facing challenges in the channels we use as well as the information we convey and how we convey it. In this interactive session, we would like to discuss how to solve these issues and what is required of marketing departments to solve them.
  • Incyte Biosciences Japan G.K. Head of Corporate Excellence, Corporate Excellence Yoko Nishida
  • AbbVie GK Group Manager, Infield Team Excellence, Customer Excellence Takashi Iwai
  • AstraZeneca K.K Manager, Customer Engagement Transformation Department, Commercial Excellence Mizuho Kitagaki

Connect MCCM Challenges for Oncology and Rare Diseases

There is no doubt that our business model is diversified such as Oncology, Rare Disease, Personalized Medicine and so on. Through the discussion at this session, it is expected to share our facing challenges to seek for best/better MCCM approach in the future.
  • Veeva Japan K.K. Vice President, Business Consulting Lead Shinichiro Akaho
  • Veeva Japan K.K. Manager, Customer Success Ryota Nishida
  • Veeva Japan K.K.

VeevaClub本会 Veeva Club

TBD
  • Veeva Japan K.K. Director, CRM Product Management Japan Shunichi Matsumoto

On-Demand Veeva CRM - Product Roadmap

Please check out our future roadmap for respective commercial products including Veeva CRM.
  • Veeva Japan K.K. Senior Product Manager, CRM Product Management Japan Kai Eriksson
  • Veeva Japan K.K. Senior Product Manager, CRM Product Management Japan Shoichi Ido

On-Demand A Day as a Digital Rep - Veeva Commercial Cloud

The activities of Reps have changed drastically. The use of digital is expanding. However, it is difficult to build relationships with HCP through digital alone, and now the key is to combine the digital with the real. This session will introduce how Veeva Commercial Cloud can support "Hybrid MR".
  • Veeva Japan K.K. General Manager, Japan Takashi Okamura
  • Veeva Japan K.K. Vice President, Business Consulting Lead Shinichiro Akaho

On-Demand Value of Veeva Business Consulting

Introducing the background, goals and value of Veeva Business consulting that launched this year.